Medical Xpress news

Medical Xpress / GLP-1 drugs might help quell sleep apnea, study suggests

A good night's sleep might be an additional benefit some gain from taking weight-loss drugs like Ozempic and Zepbound, a new study says.

Jan 5, 2026 in Overweight & Obesity
Medical Xpress / Molecular mechanism reveals how viral infection triggers aggressive leukemia

Researchers at Kumamoto University have uncovered a previously unknown molecular mechanism by which human T-cell leukemia virus type I (HTLV-1) drives the development of adult T-cell leukemia-lymphoma (ATL), one of the most ...

Jan 5, 2026 in Oncology & Cancer
Medical Xpress / Back pain is linked to worse sleep years later in men over 65

About half of older men suffer from sleep problems, back pain or both, according to Soomi Lee, associate professor of human development and family studies at Penn State. Lee recently led a study to investigate whether one ...

Medical Xpress / Tangled scar tissue may set stage for dangerous placenta condition

Placenta accreta spectrum (PAS) used to be a rare pregnancy condition, but it now affects roughly 14,000 pregnancies annually, posing a major cause of maternal death. Yet why it happens is still not well understood. Placenta ...

Medical Xpress / High-dose risankizumab trial tests staying power against psoriasis

Oregon Medical Research Center in Portland, Oregon, has led a phase 2 trial in moderate-to-severe plaque psoriasis that paired higher-than-approved doses of risankizumab with extended follow-up and found high early skin clearance ...

Jan 2, 2026 in Immunology
Medical Xpress / Creating cells that help the brain keep its cool

Researchers at Lund University in Sweden have created a method that makes it possible to transform the brain's support cells into parvalbumin-positive cells. These cells act as the brain's rapid-braking system and are significantly ...

Jan 2, 2026 in Neuroscience
Medical Xpress / Potential biomarker linked to multiple sclerosis progression and brain inflammation

A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease progression that could help identify patients most likely to benefit from new drugs.

Jan 2, 2026 in Neuroscience
Medical Xpress / AI model predicts B cell reactivity to neoantigens for improved cancer vaccines

Neoantigens are unique markers that distinguish only cancer cells. By adding B cell reactivity, cancer vaccines can move beyond one-time attacks and short-term memory to become a long-term immunity that "remembers" cancer, ...

Jan 2, 2026 in Oncology & Cancer
Medical Xpress / Tumor bacteria linked to immunotherapy resistance in head and neck cancer

Cleveland Clinic researchers have discovered that bacteria inside cancerous tumors may be key to understanding why immunotherapy works for some patients but not others.

Jan 2, 2026 in Oncology & Cancer
Medical Xpress / A mother's circadian rhythm may predict her child's vulnerability to bacterial infection

In laboratory models, researchers at The University of Texas MD Anderson Cancer Center discovered that a mother's circadian rhythms, or internal body clock, can influence the immune system states of her offspring, which can ...

Jan 2, 2026 in Genetics
Medical Xpress / Costs pose hurdle for promising new hepatitis C lab test

A new rapid test for hepatitis C could help identify many more patients who could be cured of the deadly disease, but its use may be limited unless insurers' reimbursement rises to cover its high cost, according to researchers ...

Medical Xpress / Short, intensive workouts can help fight bowel cancer

As many of us embark on an exercise or gym routine for the new year, research reveals that just 10 minutes of intense exercise could help fight cancer.

Jan 2, 2026 in Oncology & Cancer